EUVIMEDEUVIMED entdecken
Crossref

The combination of methylprednisolone and cabergoline ameliorates severe ovarian hyperstimulation syndrome in rats.

Eman Ibrahim Anwar, Marwa Mahmoud Mady, Heba Samy Shoukry, Dalia Magdi Ismail, Manar Ahmed Hussein, Fathin Ahmed Lebbe, Hagar Khaled Elgazar, Eyman Haj- Ali, Manal Ahmed Ali, Maha Guimei

Journal of Phytomedicine and Therapeutics · 2025 · 24 (2)

DOI: 10.4314/jopat.v24i2.9 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Journal of Phytomedicine and Therapeutics, 2025. Verfasst von Eman Ibrahim Anwar und 9 weiteren Autor:innen.

AbstractBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Ovarian Hyperstimulation Syndrome (OHSS) is a severe, potentially life-threatening complication of assisted reproductive technologies. Excessive vascular endothelial growth factor (VEGF) secretion leads to increased vascular permeability and fluid shifts, which are central to the syndrome's pathogenesis. Current preventive strategies, including cabergoline, have limited efficacy. This study aimed to investigate the pharmacological effects of methylprednisolone (MP), cabergoline, and their combination in ameliorating severe OHSS manifestations in a rat model. Fifty female albino rats were randomized into five groups: control, severe OHSS (untreated), MP-treated OHSS, cabergolinetreated OHSS, and MP/cabergoline combination-treated OHSS. OHSS was induced via exogenous gonadotropins followed by human chorionic gonadotropin (hCG). The outcomes assessed included body weight gain, ovarian weight, ovarian induction response including antral follicles count (AFC) and the relative follicles diameter (RFD), vascular permeability (Evans blue assay in the peritoneal aspirate), serum estradiol levels (ELISA), hematologic parameters, and histopathological changes in the ovaries, lungs, and uterus. VEGF expression was measured in ovarian tissue by immunohistochemistry method. The untreated severe OHSS group demonstrated significant increases in body and ovarian weights, AFC, RFD, Ovarian VEGF gene expression, vascular permeability,hematocrit, platelet count, D-dimer, and serum estradiol levels (P

Zitieren

APA

Anwar, E. I., Mady, M. M., Shoukry, H. S., Ismail, D. M., Hussein, M. A., Lebbe, F. A., Elgazar, H. K., Ali, E. H., Ali, M. A., & Guimei, M. (2025). The combination of methylprednisolone and cabergoline ameliorates severe ovarian hyperstimulation syndrome in rats. Journal of Phytomedicine and Therapeutics, 24(2). https://doi.org/10.4314/jopat.v24i2.9

Vancouver

Anwar EI, Mady MM, Shoukry HS, Ismail DM, Hussein MA, Lebbe FA, et al. The combination of methylprednisolone and cabergoline ameliorates severe ovarian hyperstimulation syndrome in rats. Journal of Phytomedicine and Therapeutics. 2025;24(2). doi:10.4314/jopat.v24i2.9

BibTeX
@article{Anwar2025,
  author = {Anwar, Eman Ibrahim and Mady, Marwa Mahmoud and Shoukry, Heba Samy and Ismail, Dalia Magdi and Hussein, Manar Ahmed and Lebbe, Fathin Ahmed and Elgazar, Hagar Khaled and Ali, Eyman Haj- and Ali, Manal Ahmed and Guimei, Maha},
  title = {The combination of methylprednisolone and cabergoline ameliorates severe ovarian hyperstimulation syndrome in rats},
  journal = {Journal of Phytomedicine and Therapeutics},
  year = {2025},
  volume = {24},
  number = {2},
  doi = {10.4314/jopat.v24i2.9}
}
Kostenlos starten →